Unicycive Therapeutics In... (UNCY)
NASDAQ: UNCY
· Real-Time Price · USD
4.32
0.03 (0.70%)
At close: Sep 04, 2025, 3:59 PM
4.17
-3.47%
Pre-market: Sep 05, 2025, 06:00 AM EDT
0.70% (1D)
| Bid | 4.17 |
| Market Cap | 55.16M |
| Revenue (ttm) | 568K |
| Net Income (ttm) | -31.5M |
| EPS (ttm) | -2.74 |
| PE Ratio (ttm) | -1.58 |
| Forward PE | 0.31 |
| Analyst | Buy |
| Ask | 4.47 |
| Volume | 196,316 |
| Avg. Volume (20D) | 805,214 |
| Open | 4.27 |
| Previous Close | 4.29 |
| Day's Range | 4.15 - 4.32 |
| 52-Week Range | 3.24 - 11.00 |
| Beta | 1.86 |
About UNCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol UNCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for UNCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Unicycive Therapeutics Inc. is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-29.85%
Unicycive Therapeutics shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago
-8.89%
Unicycive Therapeutics shares are trading lower after the company announced a 1-for-10 reverse stock split effective June 20, 2025.
2 weeks ago · businesswire.com
UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES--(BUSINESS WIRE)---- $UNCY--UNCY Investors Have Opportunity to Lead Unicycive Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm.
